AINDEX
Markets

Aurora Cannabis Inc. (ACB)

ACBNASDAQ-CM Medicinal Chemicals and Botanical Products

$5.14

-0.0200 (-0.39%) today

Regular session, Nov 10, 1:53 PM ET

-0.39% 1D
Market cap
$337.93m
P/E
22.4
EPS, last 4 quarters
$0.2300
Dividend yield
–
Day range
$5.10 to $5.29
52-week range
$2.56 to $6.36
Average volume
1.28m
Previous close
$5.16

Analysts

3 covering

Hold0 buy, 2 hold, 1 sell

Targets a year out average $5.33, +3.7% from here

$4.96now $5.14$5.52

Earnings

next estimate $-0.0700

Next report

Dec 2025

–

Mar 2026

+200.0%

Jun 2026

+130.8%

Sep 2026

+200.0%

estimate reported, and the surprise

Financials

No quarterly figures from the source.

News

8 latest

The company

Aurora is a global leader in medical cannabis, dedicated to improving lives through scientific expertise, proven performance, and a deep commitment to patient care. Aurora serves medical markets across Canada, Europe, Australia, and New Zealand with a portfolio of trusted, leading brands including Aurora, MedReleaf, Pedanios, IndiMed, San Raf, and Whistler Medical Marijuana Corporation. With world-class GMP-certified manufacturing facilities in Canada and Germany, and a team of industry-leading professionals, Aurora continues to expand its global footprint and deliver consistent, high-quality cannabis products with the purpose of Opening the World to Cannabis.

Sector
Health Care
Industry
Medicinal Chemicals and Botanical Products
Exchange
NASDAQ-CM
Region
North America

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.